JP2021520813A5 - - Google Patents
Info
- Publication number
- JP2021520813A5 JP2021520813A5 JP2020555518A JP2020555518A JP2021520813A5 JP 2021520813 A5 JP2021520813 A5 JP 2021520813A5 JP 2020555518 A JP2020555518 A JP 2020555518A JP 2020555518 A JP2020555518 A JP 2020555518A JP 2021520813 A5 JP2021520813 A5 JP 2021520813A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- nucleic acid
- chimeric receptor
- acid molecule
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18166498.8 | 2018-04-10 | ||
| EP18166498 | 2018-04-10 | ||
| PCT/NL2019/050212 WO2019199165A1 (en) | 2018-04-10 | 2019-04-10 | Chimeric notch receptors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021520813A JP2021520813A (ja) | 2021-08-26 |
| JP2021520813A5 true JP2021520813A5 (https=) | 2022-04-19 |
| JPWO2019199165A5 JPWO2019199165A5 (https=) | 2022-04-19 |
| JP7562417B2 JP7562417B2 (ja) | 2024-10-07 |
Family
ID=62063276
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020555518A Active JP7562417B2 (ja) | 2018-04-10 | 2019-04-10 | キメラノッチ受容体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20210139556A1 (https=) |
| EP (1) | EP3774867A1 (https=) |
| JP (1) | JP7562417B2 (https=) |
| KR (1) | KR20210008840A (https=) |
| CN (1) | CN112243442A (https=) |
| AU (1) | AU2019252878B2 (https=) |
| CA (1) | CA3096812A1 (https=) |
| IL (1) | IL277859A (https=) |
| WO (1) | WO2019199165A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116790647B (zh) * | 2023-02-06 | 2024-04-16 | 森瑞斯生物科技(深圳)有限公司 | 一种低背景、高信号强度的2-吡咯烷酮生物传感器及应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006047878A1 (en) * | 2004-11-03 | 2006-05-11 | British Columbia Cancer Agency Branch | Cancer therapeutics and methods for their use |
| CN104402998A (zh) * | 2008-07-08 | 2015-03-11 | 昂考梅德药品有限公司 | 分离的抗体 |
| SG191039A1 (en) * | 2010-12-15 | 2013-08-30 | Wyeth Llc | Anti-notch1 antibodies |
| EP2970479B1 (en) * | 2013-03-14 | 2019-04-24 | Novartis AG | Antibodies against notch 3 |
| BR112016028537A2 (pt) * | 2014-06-04 | 2017-08-22 | Hutchinson Fred Cancer Res | expansão e enxerto de células-tronco utilizando agonistas de notch 1 e/ou de notch 2 |
| FR3026744B1 (fr) * | 2014-10-06 | 2024-04-19 | Hopitaux Paris Assist Publique | Methode de generation de progeniteurs de cellules t |
| WO2016138034A1 (en) * | 2015-02-24 | 2016-09-01 | The Regents Of The University Of California | Binding-triggered transcriptional switches and methods of use thereof |
| WO2017123559A2 (en) * | 2016-01-11 | 2017-07-20 | The Board Of Trustees Of The Leland Stanford Junior University | Chimeric proteins and methods of regulating gene expression |
| JP7500195B2 (ja) * | 2016-08-23 | 2024-06-17 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | タンパク質分解により切断可能なキメラポリペプチド及びそれらの使用方法 |
| US11325957B2 (en) * | 2017-06-19 | 2022-05-10 | Cell Design Labs, Inc. | Methods and compositions for reducing the immunogenicity of chimeric notch receptors |
-
2019
- 2019-04-10 AU AU2019252878A patent/AU2019252878B2/en active Active
- 2019-04-10 EP EP19720197.3A patent/EP3774867A1/en active Pending
- 2019-04-10 WO PCT/NL2019/050212 patent/WO2019199165A1/en not_active Ceased
- 2019-04-10 KR KR1020207032411A patent/KR20210008840A/ko not_active Abandoned
- 2019-04-10 CA CA3096812A patent/CA3096812A1/en active Pending
- 2019-04-10 CN CN201980038222.3A patent/CN112243442A/zh active Pending
- 2019-04-10 JP JP2020555518A patent/JP7562417B2/ja active Active
- 2019-04-10 US US17/045,829 patent/US20210139556A1/en not_active Abandoned
-
2020
- 2020-10-07 IL IL277859A patent/IL277859A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105384825B (zh) | 一种基于单域抗体的双特异性嵌合抗原受体及其应用 | |
| JP2023053110A (ja) | キメラ抗原受容体、組成物及び方法 | |
| CN105331586B (zh) | 一种包含高效杀伤启动机制的肿瘤精准t细胞及其用途 | |
| JP2021528048A (ja) | Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| JP2025023921A (ja) | ガイダンス及びナビゲーションコントロール蛋白質並びにその生産及び使用方法 | |
| CN112074278B (zh) | Bcma-car-t细胞 | |
| JP2022500419A (ja) | 腫瘍を治療するためのナチュラルキラー細胞組成物および免疫療法の方法 | |
| KR102316091B1 (ko) | Bcma를 표적으로 하는 키메라 항원 수용체 및 이의 용도 | |
| JP2021512614A5 (https=) | ||
| RU2018147423A (ru) | Анти-PD-L1 и IL-2 цитокины | |
| JP6653775B1 (ja) | キメラ抗原受容体、核酸、キメラ抗原受容体発現プラスミド、キメラ抗原受容体発現細胞、その使用及びがん治療用の医薬組成物 | |
| JP7404279B2 (ja) | 様々な構築物最適化を備えたｔ細胞抗原カプラ | |
| CN109651511A (zh) | 一种靶向bcma的嵌合抗原受体及其应用 | |
| RU2018104703A (ru) | Опухолеспецифичное антитело против egfr и его применение | |
| JP2019536469A5 (https=) | ||
| TW202123964A (zh) | Ｈｌａ－ｇ特異性嵌合抗原受體、核酸、ｈｌａ－ｇ特異性嵌合抗原受體表達質體、表達ｈｌａ－ｇ特異性嵌合抗原受體細胞、其用途以及用於治療癌症之醫藥組合物 | |
| US20210388109A1 (en) | Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of solid tumors | |
| KR102464507B1 (ko) | 항-CD300c 단클론 항체를 포함하는 암 예방 또는 치료용 조성물 | |
| JP2023503567A (ja) | 抗－ｃｄ３００ｃ単クローン抗体を含むがん予防または治療用組成物 | |
| JP7810446B2 (ja) | Ｈｅｒｖ－ｋ抗体治療薬 | |
| CN114075287B (zh) | 人源化bcma抗体和bcma-car-t细胞 | |
| JP2021520813A5 (https=) | ||
| Asano et al. | Multimerization of anti‐(epidermal growth factor receptor) IgG fragments induces an antitumor effect: the case for humanized 528 scFv multimers | |
| Agaugue et al. | The high expression of NKG2D ligands on tumor and the lack of surface expression on healthy tissues provides a strong rationale to support NKG2D-based therapeutic approaches for cancer | |
| JP7698581B2 (ja) | 抗メソテリン抗体、抗ｃｄ３抗体又は抗ｅｇｆｒ抗体を含む融合タンパク質、それを含む二重特異性又は三重特異性抗体、及びその使用 |